Weiping Yang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 10%
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
-
- Breast Cancer Treatment Studies 5
- Cancer-related molecular mechanisms research 4
- Co-authors
- Qinghong Qin (15 shared papers)Qixing Tan (12 shared papers)Changyuan Wei (10 shared papers)Chenghong Peng (13 shared papers)Weihua Qiu (16 shared papers)Qinguo Mo (5 shared papers)Changyuan Wei (7 shared papers)Zhi-Jie Liang (4 shared papers)
- Journals
- PLoS ONE (2 papers)Oncotarget (2 papers)Biotechnology Letters (2 papers)Tumor Biology (2 papers)Biological and Pharmaceutical Bulletin (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Weiping Yang
65 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 366
- Geriatrics and Gerontology 35
- Oncology 242
- Hepatology 64
- Transplantation 20
Countries citing papers authored by Weiping Yang
This map shows the geographic impact of Weiping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Yang more than expected).
Fields of papers citing papers by Weiping Yang
This network shows the impact of papers produced by Weiping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Yang. The network helps show where Weiping Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiping Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 108 | |
| 2 | 2013 | 78 | |
| 3 | 2021 | 78 | |
| 4 | 2019 | 73 | |
| 5 | 2020 | 73 | |
| 6 | 2021 | 56 | |
| 7 | 2017 | 53 | |
| 8 | 2014 | 52 | |
| 9 | Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance. | 2015 | 50 |
| 10 | Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy. | 2014 | 47 |
| 11 | 2006 | 42 | |
| 12 | 2015 | 41 | |
| 13 | 2010 | 40 | |
| 14 | 2017 | 40 | |
| 15 | 2019 | 38 | |
| 16 | 2013 | 31 | |
| 17 | 2009 | 23 | |
| 18 | 2018 | 23 | |
| 19 | 2019 | 23 | |
| 20 | 2019 | 22 |
About Weiping Yang
Weiping Yang is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Epidemiology, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Thyroid and Parathyroid Surgery (7 papers), Breast Cancer Treatment Studies (5 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers), Minerals Flotation and Separation Techniques (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (366 citations), Geriatrics and Gerontology (35 citations), Oncology (242 citations), Hepatology (64 citations) and Transplantation (20 citations). Weiping Yang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qinghong Qin, Qixing Tan, Changyuan Wei, Chenghong Peng, Weihua Qiu, Qinguo Mo, Changyuan Wei, Zhi-Jie Liang, Maojian Chen and Jiqi Yan. Their work appears in journals such as PLoS ONE, Oncotarget, Biotechnology Letters, Tumor Biology and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.